Treatment with an Anti-CK2 Synthetic Peptide Improves Clinical Response in COVID-19 Patients with Pneumonia. A Randomized and Controlled Clinical Trial

di Cruz, Leticia R., Baladrón, Idania, Rittoles, Aliusha, Díaz, Pablo A., Valenzuela, Carmen, Santana, Raúl, Vázquez, Maria M., García, Ariadna, Chacón, Deyli, Thompson, Delvin, Perera, Gustavo, González, Ariel, Reyes, Rafael, Torres, Loida, Pérez, Jesus, Valido, Yania, Rodriguez, Ralysmay, Vázquez-Bloomquist, Dania M., Rosales, Mauro, Ramón, Ailyn C., Pérez, George V., Guillén, Gerardo, Muzio, Verena, Perera, Yasser, Perea, Silvio E.
Pubblicato in ACS Pharmacol Transl Sci (2020)